StockData
NewAmsterdam Pharma Co N.V. logo

NewAmsterdam Pharma Co N.V. (NAMS) stock

NAMSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NAMSW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$19.39−0.07 (-0.36%)

Close on Nov 17, 2026Market cap $2.32BP/E –Yield –

NewAmsterdam Pharma total assets

Total assets on the balance sheet at the end of each period.

NewAmsterdam Pharma's total assets was $704.45M at Jun 30, 2026. For fiscal 2025 it was $769.28M, down 11.0% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$769.28M-11.0%
FY2024Dec 31, 2024$864.62M+149.1%
FY2023Dec 31, 2023$347.10M-27.5%
FY2022Dec 31, 2022$478.50M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$704.45M-13.6%
Q1 FY2026Mar 31, 2026$732.64M-10.5%
Q4 FY2025Dec 31, 2025$769.28M-11.0%
Q3 FY2025Sep 30, 2025$786.43M+79.1%
Q2 FY2025Jun 30, 2025$815.11M+82.5%
Q1 FY2025Mar 31, 2025$818.41M+67.5%
Q4 FY2024Dec 31, 2024$864.62M+149.1%
Q3 FY2024Sep 30, 2024$439.19M-8.2%
Q2 FY2024Jun 30, 2024$446.69M–
Q1 FY2024Mar 31, 2024$488.46M–
Q4 FY2023Dec 31, 2023$347.10M–
Q4 FY2022Dec 31, 2022$478.50M–

More NewAmsterdam Pharma figures

See a number that looks wrong?